NSAIDs Flashcards

(47 cards)

1
Q

NSAIDs - MoA

A

Inhibition of prostaglandin synthesis by competitive cyclooxygenase (COX) inhibition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

NSAIDs - Clinical use

A
Low dose: mild-moderate pain, antipyretic 
Higher doses: inflammation. 
Postop pain (often combined with opioid) 
Chronic pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

NSAIDs - Contraindications

A

Contraind: previous severe hypersensitivity to salicylates (cross-sensitivity)

Generally not recommended for second half of pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

NSAIDs - Adverse effects

A
GI bleeding, Peptic ulcers
Renal and hepatic dysfunction. 
Lithium toxicity. 
Hyperkalemia 
Platelet inhibition 
Premature closure of ductus arteriosus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

NSAIDs - Interactions

A

Inhibit renal excretion of lithium.

Reduced clearance of aminoglycosides & methotrexates.

Interfere with antihypertensive effect of: diuretics, β-adrenoceptor antagonists, angiotensin inhibitors & others.

Potassium-sparing diuretics: hyperkalemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Salicylates - MoA

A

Nonspecific inhibition of COX

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Salicylates - Clinical use

A

Pain, fever, inflammation

Prophylaxis for MI, stroke, thromboembolic disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Salicylates - Contraindication

A

Avoid in children: Reye syndrome (in virus infected children).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Salicylates - Overdose treatment

A

Vomiting
IV sodium bicarbonate (alkalization of the urine, increases ionization and elimination)
Fluids, electrolytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Salicylates - Adverse effects

A

Reye syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Aspirin - MoA

A

Forms covalent, irreversible inhibition of COX in platelets

Nonspecific inhibition of COX in peripheral tissues and CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Aspirin - Clinical use

A

Analgesic
Antipyretic
Anti-inflammatory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Aspirin - Special considerations

A

Longer thromboxane effect than other salicylates.

Inhibits platelet aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Aspirin - Adverse

A

Aspirin toxicity
High dose: Tinnitus (early sign of salicylate toxicity)

Hyperventilation
Fever, dehydration, severe metabolic acidosis
If not treated: Shock, coma, organ system failure, death

Hypoprothrombinemia – impairment of hemostatis and bleeding

Hypersensitivity – anaphylaxis (mostly pt with asthma, nasal polyps, chronic urticaria)

Symptoms of aspirin intolerance: vasomotor rhinitis, angioedema, urticaria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Aspirin - Interactions and contraindication

A

Adm with antacids: slows absorption rate

Contraindication: Persons who have has severe hypersensitivity reaction to aspirin or another salicylate should not be treated with another type of NSAID (cross-sensitivity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Ibuprofen - MoA

A

Reversible and nonselective inhibition of COX

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Ibuprofen, Ketoprofen, Naproxen - Clinical use

A

Analgesic, antipyretic and anti-inflammatory effects
Low dose: mild pain and inflammation
Higher dose: arthritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Ibuprofen - Special considerations

A

Combo with H2 receptor antagonist famotidine for RA and OA (less GI ulcers)

Half-life: 2h

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Ibuprofen - Adverse effects

A

GI irritation, nausea, dyspepsia, bleeding.

Long-term: PUD, Hepatotoxicity, renal toxicity

Failure of ingesting adequate fluid: acute renal failure

20
Q

Naproxen - Special considerations

A

Combo with esomeprazole: arthritis, reduces risk of ulcers

Longer halflife (14h)

21
Q

Acetaminophen - MoA

A

COX3 inhibitor

22
Q

Acetaminophen - Clincal use

A

Mild fever and pain
Mild arthritis
Analgesic and antipyretic effects via inhibitor of COX

23
Q

Acetaminophen - Special considerations

A

Safe for children with viral infection

24
Q

Acetaminophen - Overdose treatment

A

Acetylcysteine

25
Acetaminophen - Adverse effects
Fewer GI problems High dose: hepatic necrosis, hepatotoxicity Long-term use: Increased risk of renal dysfunction
26
Acetaminophen - Interactions
Small amount converted by CYT P-450 to potentially hepatotoxic quinone intermediate Patients at risk for hepatotoxicity (f.ex. overdose): given acetylcysteine (conjugates quinone and renders it harmless)
27
Indomethacin - Clinical use
Reserved for moderate/severe inflammation disorders Patent ductus arteriosus (indomethacin inhibit synthesis of prostaglandins and causes the closure)
28
Indomethacin - Adverse effects
Nephrotoxicity with triamterene Highest incidence of GI and CNS side effects Hematologic toxicity
29
Indomethacin - Interaction
Reduces natriuretic effect of diuretics. | With triamterene: nephrotoxicity
30
Sulindac - MoA
Prodrug converted to active sulfide metabolite. Parent compound sulindac sulfoxide is inactive in COX inhibition
31
Sulindac - Clinical use
RA | Adenomas in polyp disease
32
Ketorolac - Clinical use
Analgesic activity Post-op moderate pain in dentistry Allergic conjunctivitis Post-op ocular infl.
33
Ketorolac - Special considerations and Caution
``` Potent analgesic (comparable to morphine) Ophthalmic solution of ocular inflammation. Treatment limited to 5 days ``` Caution in patients with renal/hepatic disease
34
Ketorolac - Adverse effects
Fewer GI and CNS effects than opioids. Hematologic toxicity Increased risk of renal or hepatic impairment
35
Piroxicam - Clinical use
Anti-inflammatory | Chronic RA treatment
36
Piroxicam - Special considerations
Long half-life (50h)
37
Nabumetone - MoA
Weak COX inhibitory activity in vitro, but converted to active metabolites with potent inhibition in vivo
38
Etodolac, meloxicam - MoA
More selective for COX-2 than typical NSAIDs
39
Diclofenac - Clinical use
Osteoarthritis
40
Selective COX-2 inhibitors
Celecoxib Rofecoxib (Removed from market) Valdecoxib (Removed from market)
41
Selective COX-2 inhibitors - MoA
Potent anti-inflammatory action
42
Selective COX-2 inhibitors - Special
Decreased risk of cancer (esp colon cancer)
43
Celecoxib - Clinical use
Rheumatoid arthritis | Osteoarthritis
44
Celecoxib - MoA
Selective COX-2 inhibition Analgesic antipyretic antiinflammatory
45
Celecoxib - Special
Does not inhibit platelet aggregation (platelet contain only COX-1)
46
Celecoxib - Adverse effects
Increased risk of cardiovascular events | Low incidence: diarrhea, dyspepsia, abd pain
47
Celecoxib - Interactions
Metabolized by CYT P-450 Metabolism is inhibited and increased serum levels by fluconazole, fluvastatin, zafirlukast.